Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient Biochemotherapy (CDDP, DTIC, GM-CSF, IFN-a2b, IL-2) for Advanced Melanoma
NCT00004141Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Aug 1998
- Primary completion
- Jan 2003
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, dacarbazine, sargramostim, interferon alfa-2b, aldesleukin in melanoma, sponsored by University of Chicago. Started Aug 1998; status: completed.
02
Drugs
cisplatindacarbazinesargramostiminterferon alfa-2baldesleukin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00004141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004141.